(Wall Street Journal) – Employers that embraced paying for weight-loss drugs are now reckoning with the high costs, forcing growing numbers to dial back or cut off their reimbursement because they can’t afford it.

The companies are putting in place restrictions such as limiting use to workers with high body-mass indexes, or a $20,000 cap, while others have eliminated coverage altogether. They can’t sustain the spending, they say, and question whether the medications are reaching the right patients. (Read More)